Searching journal content for articles similar to Lee et al. 31 (9): 1638.

Displaying results 1-10 of 17
For checked items
  1. ...Institute for Precision Medicine, University of Washington, Seattle, Washington 98195, USA Corresponding authors: rmyers@hudsonalpha.org, gcooper@hudsonalpha.orgAbstractMassively parallel reporter assays (MPRAs) are useful tools to characterize regulatory elements in human s. An aspect of MPRAs...
  2. ...-seq), like other episomal massively parallel reporter assays (MPRAs) (Melnikov et al. 2012; Patwardhan et al. 2012), directly quantifies enhancer activity by relying on transcription factors within a host cell system, thereby removing any chromatin-associated biases (Arnold et al. 2013). STARR-seq takes...
  3. ....goldys@unsw.edu.auAbstractMicroscopy and omics are complementary approaches to probe cellular molecular states in health and disease, combining granularity with scalability. However, integrating both imaging- and sequencing-based assays on the same cell has proven challenging. This study demonstrates a new approach called Spectral...
  4. ...for accurate cleavage site prediction is yet to be established.Recent progress in large-scale DNA synthesis promoted the establishment of massively parallel reporter assays (MPRAs) (Sharon et al. 2012; Goodman et al. 2013; Kheradpour et al. 2013; Mogno et al. 2013; Smith et al. 2013; Noderer et al. 2014...
  5. ...with thousands of distinct barcodes, and the error reduction process as described in this study provide a fundamental solution for accurate and phased WGS from IVF biopsies (and other scarce samples), applicable for both current massively parallel short-read technologies and future longer read, single...
  6. ...MinION flowcell to be flushed, stored, and ultimately reused.DiscussionThe capabilities of the dominant Illumina sequencing technology—producing massive numbers of short reads—have shaped the development of sequencing-based assays more than any other single factor.Although long-read sequencers...
  7. ...microbial evolution to human cancer genetics. However, despite the cost and throughput advances associated with massively parallel sequencing, it remains challenging to reliably detect mutations that are present at a low relative abundance in a given DNA sample. Here we describe smMIP, an assay...
  8. ...genotyping arrays; for example, (1) there is a lack of ascertainment bias with regard to which variants/sites on the are assayed, (2) sequence data can be used to discover novel variation both at the sample or population level (such as in Tran et al. 2020; Liu et al. 2018), (3) massively parallel low...
  9. ..., and we will focus on two widely used approaches, chromatin accessibility mapping and ChIP-seq. The accessibility of chromatin to various enzymes such as DNase I is a well-established indicator of genomic regulatory activity. High-throughput sequencing-based assays such as DNase-seq and ATAC-seq exploit...
    OPEN ACCESS ARTICLE
  10. ...of samples, as these approaches are not easily scalable. Alfano et al. (2022) evaluated a multiplex Cas9 enrichment approach using nCATS with ONT native barcoding (EXP-NBD104 kit) and reported >10-fold lower enrichment compared to a singleplex run, with 70% unclassified reads. These results were consistent...
    OPEN ACCESS ARTICLE
For checked items

Preprint Server